Table 1 Clinical characteristics of lung transplant recipients(\(\bar{x}\) ± s or n)
Variables | Before Propensity Score Matching | After Propensity Score Matching | ||||
|---|---|---|---|---|---|---|
ECMO group (n = 117) | Non-ECMO group (n = 112) | P | ECMO group (n = 37) | Non-ECMO group (n = 37) | P | |
Gender, males/females | 80/37 | 101/11 | 0.00 | 27/10 | 30/7 | 0.41 |
Age, years | 55.24 ± 13.27 | 55.54 ± 11.25 | 0.04 | 55.76 ± 12.54 | 53.08 ± 13.62 | 0.38 |
BMI | 19.77 ± 4.15 | 19.62 ± 4.33 | 0.78 | 20.01 ± 3.58 | 19.81 ± 5.24 | 0.84 |
Intraoperative blood loss (ml) | 1308.12 ± 1588.12 | 543.03 ± 1003.58 | 0.00 | 875.68 ± 950.12 | 993.76 ± 1626.22 | 0.70 |
Intraoperative RBC transfusion(units) | 6.96 ± 7.36 | 1.17 ± 3.07 | 0.00 | 4.07 ± 4.95 | 3.26 ± 4.67 | 0.47 |
Operation time(min) | 466.98 ± 133.03 | 318.66 ± 126.74 | 0.00 | 375.03 ± 111.84 | 417.00 ± 139.36 | 0.16 |
SLT/BLT(n) | 37/80 | 74/38 | 0.00 | 19/18 | 11/26 | 0.06 |
Transplant indication | 0.00 | 0.00 | ||||
COPD | 7(6%) | 52(46%) | 1(3%) | 10(27%) | ||
Lung fibrosis | 14(12%) | 6(5%) | 5(14%) | 0(0%) | ||
IPF | 5(4%) | 4(4%) | 2(5%) | 0(0%) | ||
Pneumosilicosis | 7(6%) | 5(4%) | 3(8%) | 1(3%) | ||
Bronchiectasis | 11(9%) | 3(3%) | 0(0%) | 2(5%) | ||
NISP | 54(46%) | 30(27%) | 20(54%) | 13(35%) | ||
Others | 19(16) | 12(11%) | 6(16%) | 11(30%) | ||